» Articles » PMID: 37257450

Multi-omics Blood Atlas Reveals Unique Features of Immune and Platelet Responses to SARS-CoV-2 Omicron Breakthrough Infection

Abstract

Although host responses to the ancestral SARS-CoV-2 strain are well described, those to the new Omicron variants are less resolved. We profiled the clinical phenomes, transcriptomes, proteomes, metabolomes, and immune repertoires of >1,000 blood cell or plasma specimens from SARS-CoV-2 Omicron patients. Using in-depth integrated multi-omics, we dissected the host response dynamics during multiple disease phases to reveal the molecular and cellular landscapes in the blood. Specifically, we detected enhanced interferon-mediated antiviral signatures of platelets in Omicron-infected patients, and platelets preferentially formed widespread aggregates with leukocytes to modulate immune cell functions. In addition, patients who were re-tested positive for viral RNA showed marked reductions in B cell receptor clones, antibody generation, and neutralizing capacity against Omicron. Finally, we developed a machine learning model that accurately predicted the probability of re-positivity in Omicron patients. Our study may inspire a paradigm shift in studying systemic diseases and emerging public health concerns.

Citing Articles

Short-term antiretroviral therapy may not correct the dysregulations of plasma virome and cytokines induced by HIV-1 infection.

Ma Y, Zhang M, Wang Z, Cao L, Li Y, Wan Z Virulence. 2025; 16(1):2467168.

PMID: 39950859 PMC: 11866967. DOI: 10.1080/21505594.2025.2467168.


Antiviral Activity and Underlying Mechanism of Aqueous Extract for Treating SARS-CoV-2.

Feng Y, Ge Q, Gao J, Wu Z, Zhang Y, Mao H Molecules. 2025; 30(2).

PMID: 39860255 PMC: 11767572. DOI: 10.3390/molecules30020387.


An allelic atlas of immunoglobulin heavy chain variable regions reveals antibody binding epitope preference resilient to SARS-CoV-2 mutation escape.

Deng W, Niu X, He P, Yan Q, Liang H, Wang Y Front Immunol. 2025; 15():1471396.

PMID: 39840032 PMC: 11746035. DOI: 10.3389/fimmu.2024.1471396.


4D-DIA Proteomics Uncovers New Insights into Host Salivary Response Following SARS-CoV-2 Omicron Infection.

de Lima I, Cataldi T, Brites C, Labate M, Vaz S, Deminco F J Proteome Res. 2025; 24(2):499-514.

PMID: 39803891 PMC: 11812090. DOI: 10.1021/acs.jproteome.4c00630.


A comparative cohort study of post-COVID-19 conditions based on physical examination records in China.

Liu Z, Hu B, Zeng T, You C, Li N, Liu Y EBioMedicine. 2025; 112:105549.

PMID: 39753031 PMC: 11753975. DOI: 10.1016/j.ebiom.2024.105549.


References
1.
Lopez-Otin C, Kroemer G . Hallmarks of health. Cell. 2021; 184(7):1929-1939. DOI: 10.1016/j.cell.2021.03.033. View

2.
Middleton E, He X, Denorme F, Campbell R, Ng D, Salvatore S . Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020; 136(10):1169-1179. PMC: 7472714. DOI: 10.1182/blood.2020007008. View

3.
Ren X, Wen W, Fan X, Hou W, Su B, Cai P . COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021; 184(23):5838. PMC: 8582084. DOI: 10.1016/j.cell.2021.10.023. View

4.
Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L . BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022; 608(7923):593-602. PMC: 9385493. DOI: 10.1038/s41586-022-04980-y. View

5.
Chen Z, Xu W, Ma W, Shi X, Li S, Hao M . Clinical laboratory evaluation of COVID-19. Clin Chim Acta. 2021; 519:172-182. PMC: 8086377. DOI: 10.1016/j.cca.2021.04.022. View